A previous study revealed that blockade of the PD-1/PD-L1 pathway with PD-1 orPD-L1 antibodies could inhibit the tumorigenic effect of colon cancer stem cells (33). This evidence concerns the gene PDCD1 and malignant colon neoplasm.